ABT?737 increases cisplatin sensitivity through the ROS?ASK1?JNK MAPK signaling axis in human ovarian cancer cisplatin?resistant A2780/DDP cells. Li X, Guo Y, Xing Z, Gong T, et al. Oncol Rep 2024;52:122.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li X, Guo Y, Xing Z, Gong T, et al. ABT?737 increases cisplatin sensitivity through the ROS?ASK1?JNK MAPK signaling axis in human ovarian cancer cisplatin?resistant A2780/DDP cells. Oncol Rep 2024;52:122.
PMID: 39054955